Protocol Ledger

NCT05733624 · Phase II · COMPLETED

Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis

Interventional Phase II clinical trial protocol NCT05733624 sponsored by SCAI Therapeutics in Ophthalmology and Sensory, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-01-05 Enrollment: 116 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05733624
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)116 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05733624
Protocol FieldVerified Registry Value
NCT IdentifierNCT05733624
Consolidated Lead SponsorSCAI Therapeutics
Therapeutic Condition CohortOphthalmology and Sensory
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment116 participants (ACTUAL)
Registered Start Date2023-01-05
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05733624
Hospital Research SiteLocationSite Profile
Kyungpook National University HospitalDaegu, South KoreaOpen Hospital Dossier ->
Asan Medical CenterSeoul, South KoreaOpen Hospital Dossier ->
Kangbuk Samsung HospitalSeoul, South KoreaOpen Hospital Dossier ->
Korea University Anam HospitalSeoul, South KoreaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Ophthalmology and Sensory Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI